What question did this study set out to answer?

To measure the direct costs and cost-effectiveness of a nurse-led cardiovascular screening and intervention programme in British general practice.

May 18, 1996BMJOpen Access

Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study

View Full Paper

Ask AI

Bookmark

Why the study?

Is a nurse-led family-centered cardiovascular screening and intervention program cost-effective for reducing coronary risk?

Key Points

To measure the direct costs and cost-effectiveness of a nurse-led cardiovascular screening and intervention programme in British general practice.
Cost-effectiveness analysis conducted alongside a randomised controlled trial across 13 general practices in Britain.
Included 4,185 men aged 40–59 years and their 2,827 partners who underwent family-centred, nurse-led risk screening and risk-stratified follow-up.
Combined trial-derived clinical and resource utilisation data with external unit costs to estimate total short-term costs and cost per 1% reduction in coronary risk at one year.
Direct programme implementation cost was £63 per person (95% CI, £60 to £65) for one year.
Overall short-term health service costs were £77 per man (95% CI, £29 to £124) compared with £13 per woman (95% CI, -£48 to £74) due to differing resource use.
The cost per 1% reduction in coronary risk at one year was £5.08 per man (£5.92 including broader health service costs) and £5.78 per woman (£1.28 when accounting for wider health service savings).

Structured PICO

Is a nurse-led family-centered cardiovascular screening and intervention program cost-effective for reducing coronary risk?

Population

7,012 subjects (4,185 men aged 40-59 and their 2,827 partners) from 13 general practices across Britain

Intervention

Nurse-led cardiovascular screening and intervention programme using a family-centred approach, with follow-up according to degree of risk

Outcome

Cost of the programme itself; overall short-term cost to NHS; cost per 1% reduction in coronary risk at one year

A nurse-led family-centered cardiovascular screening program costs approximately £63 per person annually, with differing broader health service costs between men and women.

Limitations

The broader impact on drug costs and use of other health care resources is uncertain, and larger trials will be needed to estimate these important effects

Authors

DWDavid WonderlingNational Institute for Health and Care Excellence MBMartin BuxtonBrunel University of London AKA L KinmonthUniversity of East Anglia

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports low per-person costs for nurse-led screening; leaves open whether adoption improves clinical outcomes.

Cite This Study

Wonderling et al. (1996) studied this question.

synapsesocial.com/papers/6a8a84321fb56efa37d4a66e https://doi.org/10.1136/bmj.312.7041.1269

View Full Paper

Ask AI

Bookmark

Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Also Consider

Also Consider